1. Home
  2. List
Reference Patent

Reference - List

  • 12 Hits
  • Search Condition : Filter (MeSH = Administration, Intravenous)
Species Resource Title
Human and Animal Cells MKN45(RCB1001) Neutralizing monoclonal antibodies improve biodistribution of intravenously administered oncolytic adenovirus in human CD46-transgenic mice.
Human and Animal Cells Colon-26(RCB2657) Intravenous administration of 90Y-labeled polyoxazoline combined with tumor heating potently inhibits tumor growth in mice.
Human and Animal Cells A549(RCB0098) Gel-in-water nanodispersion for potential application in intravenous delivery of anticancer drugs.
Pathogenic eukaryotic microorganisms Aspergillus fumigatus IFM 62234 Successful treatment of Aspergillus empyema using combined intrathoracic and intravenous administration of voriconazole: A case report.
Human and Animal Cells LM8(RCB1450) Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy.
Rats W-Tg(CAG-GFP)184Ys (StrainID=525) Intravenous delivery of mesenchymal stem cells protects both white and gray matter in spinal cord ischemia.
Human and Animal Cells B16 F10(RCB2630) In vivo biocompatibility, pharmacokinetics, antitumor efficacy, and hypersensitivity evaluation of ionic liquid-mediated paclitaxel formulations.
Human and Animal Cells MKN7(RCB0999) Locoregional therapy with α-emitting trastuzumab against peritoneal metastasis of human epidermal growth factor receptor 2-positive gastric cancer in mice.
Human and Animal Cells Hep G2 Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
Human and Animal Cells OS-RC-2(RCB0735) Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system.
Human and Animal Cells HuH-7 Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.
Human and Animal Cells DU145(RCB2143) Improving the bioavailability and anticancer effect of the PCA-1/ALKBH3 inhibitor HUHS015 using sodium salt.